Effect of dexamethasone in hospitalized patients with COVID-19–preliminary report
…, N Staplin, C Brightling, A Ustianowski, E Elmahi… - MedRxiv, 2020 - medrxiv.org
Background Coronavirus disease 2019 (COVID-19) is associated with diffuse lung damage.
Corticosteroids may modulate immune-mediated lung injury and reducing progression to …
Corticosteroids may modulate immune-mediated lung injury and reducing progression to …
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
…, J Emberson, A Palfreeman, J Raw, E Elmahi… - The Lancet, 2020 - thelancet.com
Background Lopinavir–ritonavir has been proposed as a treatment for COVID-19 on the basis
of in vitro activity, preclinical studies, and observational studies. Here, we report the results …
of in vitro activity, preclinical studies, and observational studies. Here, we report the results …
Dexamethasone in hospitalized patients with Covid-19-preliminary report
…, C Brightling, A Ustianowski, E Elmahi… - The New England …, 2020 - kclpure.kcl.ac.uk
Background: Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage.
Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce …
Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce …
Does self-reported pregnancy loss identify women at risk of an adverse cardiovascular phenotype in later life? Insights from UK Biobank
E Elmahi, MM Sanghvi, A Jones, CYL Aye… - Plos one, 2019 - journals.plos.org
Introduction Cardiovascular disease (CVD) is more common in women who have had
pregnancy complications such as spontaneous pregnancy loss. We used cross-sectional data …
pregnancy complications such as spontaneous pregnancy loss. We used cross-sectional data …
Cardiometabolic and reproductive health in young women: Making the right choices
E Elmahi, P Leeson - European Journal of Preventive …, 2018 - journals.sagepub.com
Vascular disorders are one of the largest causes of mortality and morbidity in women. 1 Despite
this, women remain underrepresented in cardiovascular prevention studies partly due to …
this, women remain underrepresented in cardiovascular prevention studies partly due to …
Do young women need treatment for hypertension after pregnancy complications?
CYL Aye, E Elmahi, H Boardman… - Journal of the American …, 2018 - Am Heart Assoc
Pregnancy complications, such as hypertensive disorders of pregnancy, are well established
as independent risk factors for cardiovascular diseases in later life in both the mother1, 2 …
as independent risk factors for cardiovascular diseases in later life in both the mother1, 2 …
[PDF][PDF] Design and Production of Textile Fabrics Waste from Sudanese Garment Factories
EEE Abdelgadir, RAM Asad, AEA Elabid… - academia.edu
The textile and apparel industry is one of the most significant industrial sectors in the world,
however, it generates a large number of textiles and apparel waste before and after …
however, it generates a large number of textiles and apparel waste before and after …
[PDF][PDF] Antibacterial and antioxidant properties of some selected egyptian plants
MA Hala, H Einas, S Al-Shimaa - Аннали Мечниківського …, 2017 - irbis-nbuv.gov.ua
Herbal medicines are in great demand in both developed and developing countries as a
source of primary health care that has been used by mankind all over the world in the form of …
source of primary health care that has been used by mankind all over the world in the form of …
Thromboinflammation and antithrombotics in COVID-19: accumulating evidence and current status
JM Connors, PM Ridker - JAMA, 2022 - jamanetwork.com
Thrombotic complications of SARS-CoV-2 infection were recognized early in the pandemic,
when infected patients often presented with abnormal coagulation findings and acute …
when infected patients often presented with abnormal coagulation findings and acute …
[CITATION][C] Effect of dexamethasone in hospitalized patients with COVID‐19: preliminary report
…, L Louise, S Natalie, B Christopher, U Andrew, E Einas… - MedRxiv, 2020